Screener
Nuvation Bio NUVB Income Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $31.69M+556% | $83.23M+2,599% | $41.87M+633% | $13.12M+1,705% | $4.83M+237% | ||
| $30.66M+12.1% | $35.05M+42.5% | $34.3M+17.1% | $28.85M+4.0% | $27.36M-6.4% | ||
| $42.59M+10.7% | $38.31M+8.2% | $40.33M+54.3% | $37.36M+90.8% | $38.48M+138% | ||
| $82.72M+20.9% | $79.35M+27.8% | $83.92M+34.2% | $66.21M+39.9% | $68.42M-85.5% | ||
| $6.76M+1,505% | $6.71M+12,322% | $6.67M+7,398% | $6.53M+5,345% | $421K+219% | ||
| -$11.8M-358% | $1.52M-73.7% | —— | $642K-90.7% | $4.58M-41.9% | ||
| -$62.84M-6.5% | $5.4M+110% | -$36.59M+26.0% | -$55.79M-35.4% | -$59.01M+87.2% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| -$62.84M-6.5% | $5.4M+110% | -$36.59M+26.0% | -$55.79M-35.4% | -$59.01M+87.2% | ||
| -198.3%+1,023pp | 6.5%+1,733pp | -87.4%+778pp | -425.2%+5,243pp | -1,220.9%+31,008pp | ||
| -$0.18-5.9% | $0.01+106% | -$0.11— | -$0.16-6.7% | -$0.17+91.0% | ||
| -$50.5M+20.1% | $4.42M+108% | -$33.5M+37.6% | -$55.9M-16.6% | -$63.23M+86.6% | ||
| -159.4%+1,149pp | 5.3%+1,908pp | -80%+861pp | -426.1%+6,168pp | -1,308.4%+31,454pp | ||
| -$51.04M+19.7% | $3.88M+107% | -$34.04M+36.9% | -$56.43M-17.3% | -$63.59M+86.5% |
FAQ
- What is Nuvation Bio's revenue?
- Nuvation Bio (NUVB) generated $169.9M in revenue over the trailing twelve months, up 1083.6% year over year.
- Is Nuvation Bio profitable?
- Nuvation Bio is not currently profitable: it reported a net loss of $149.8M over the trailing twelve months, a -88.2% net margin.
- What are Nuvation Bio's profit margins?
- Gross margin is 54.3% and operating margin is -81.0%, with a -88.2% net margin.
- What is Nuvation Bio's earnings per share?
- Nuvation Bio's diluted EPS over the trailing twelve months is $-0.44.
- Where does Nuvation Bio's income statement data come from?
- Every line is extracted from Nuvation Bio's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
